Mediplex sells three-property medical office portfolio in suburban Philadelphia

Mediplex Property Group has sold a three-building healthcare portfolio totaling about 50,000 square feet across suburban Philadelphia. The deal closes a development cycle for the properties and gives Mediplex capital to pursue new build-to-suit and sale-leaseback opportunities.

Why it matters: - The sale closes out Mediplex Property Group’s investment cycle on three healthcare assets developed for physician users. - The transaction frees capital for new assignment-driven de novo development and sale-leaseback deals. - The portfolio adds to the supply of outpatient-focused medical real estate in suburban Philadelphia.

What happened: - Mediplex Property Group completed the sale of three healthcare properties totaling about 50,000 square feet across suburban Philadelphia. - The portfolio included Mediplex Abington in Abington, Pennsylvania; Mediplex East Norriton in East Norriton, Pennsylvania; and Mediplex Newtown in Newtown, Pennsylvania. - The properties were sold to a privately held institutional investment group.

The details: - Mediplex Abington is a 20,000-square-foot Class A medical office building. - Mediplex East Norriton is a 17,200-square-foot medical office and ambulatory surgery center complex. - Mediplex Newtown is a 12,800-square-foot specialty medical facility. - Mediplex developed the properties over the past seven years as part of its build-to-suit model for established healthcare providers. - The facilities supported outpatient uses including neurology, ambulatory surgery, pain management, physical therapy, reproductive medicine, imaging and related specialty care. - Jeffrey Goldstein, principal of Mediplex Property Group, said the sale completes the investment cycle for three healthcare projects developed in close partnership with physician occupants. - Goldstein said each project was designed around the specific needs of its providers and was intended to create long-term value for healthcare organizations and investment partners.

Between the lines: - The sale reinforces Mediplex’s focus on ground-up construction and adaptive reuse in healthcare real estate. - The portfolio also reflects a model that often includes physician co-investment, which can align operator needs with investor returns. - The transaction suggests continued demand for outpatient medical properties with stable tenant demand and specialized use cases.

What's next: - Mediplex plans to redeploy the sale proceeds into new assignment-driven de novo development. - The company also expects to pursue additional sale-leaseback opportunities. - Mediplex continues to market itself as a developer for physician practices, regional health systems and national outpatient care providers.

The bottom line: - Mediplex turned a three-asset suburban Philadelphia healthcare portfolio into fresh capital for its next round of medical real estate projects.